| 2015-02 |
Effects of genetic variants of ADH1B and ALDH2 and social network on continued alcohol drinking among young adolescents in Taiwan |
Drug and Alcohol Dependence. 2015 Feb;147:38-45. |
 |
| 2014-05 |
Assessment of CYP450 genetic variability effect on methadone dose and tolerance |
Pharmacogenomics. 2014 May;15(7):977-986. |
|
| 2014-04 |
The association of genetic polymorphisms in the kappa-opioid receptor 1 gene with body weight, alcohol use, and withdrawal symptoms in patients with methadone maintenance |
Journal of Clinical Psychopharmacology. 2014 Apr;34(2):205-211. |
|
| 2013-12 |
Pharmacogenomics study in a Taiwanese methadone maintenance cohort |
Journal of Food and Drug Analysis. 2013 Dec;21(4 Suppl.):S62-S68. |
|
| 2013-11 |
Comparison of escitalopram and paroxetine in the treatment of major depressive disorder |
International Clinical Psychopharmacology. 2013 Nov;28(6):339-345. |
|
| 2013-09 |
Functional genetic polymorphisms in CYP2C19 Gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort |
OMICS :A Journal of Integrative Biology. 2013 Sep;17(10):519-526. |
|
| 2013-07 |
CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions |
Pharmacogenomics. 2013 Jul;14(10):1191-1201. |
|
| 2013-04 |
Psychotropic drugs and risk of motor vehicle accidents: A population-based case-control study |
British Journal of Clinical Pharmacology. 2013 Apr;75(4):1125-1133. |
|
| 2013-02 |
OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: A cross sectional study |
Journal of Human Genetics. 2013 Feb;58(2):84-90. |
|
| 2013-02 |
PXR polymorphisms interacted with CYP2B6 polymorphisms on methadone metabolites |
Journal of Clinical Psychopharmacology. 2013 Feb;33(1):137-140. |
|
| 2012-10 |
Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients |
European Neuropsychopharmacology. 2012 Oct;22(10):695-703. |
|
| 2012-10 |
Overlapping prescriptions of stimulants for children and adolescents with attention-deficit hyperactivity disorder |
Psychiatric Services. 2012 Oct;63(10):1011-1018. |
|
| 2012-07 |
Gender differences in widowhood effects among community-dwelling elders by causes of death in Taiwan |
Annals of Epidemiology. 2012 Jul;22(7):457-465. |
|
| 2012-04 |
ADRA1A gene is associated with BMI in chronic schizophrenia patients exposed to antipsychotics [Erratum:Pharmacogenomics Journal. 2010 Feb;10(1): 30-39.] |
Pharmacogenomics Journal. 2012 Apr;12(2):184. |
|
| 2012-03 |
CYP1A2 genetic polymorphisms associated with antidepressant escitalopram metabolism and adverse reactions at early stage |
Clinical Pharmacology and Therapeutics. 2012 Mar;91(Suppl. 1):S62. |
|
| 2011-10 |
Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients |
Pharmacogenomics. 2011 Oct;12(10):1397-1406. |
|
| 2011-08 |
CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer |
Journal of Clinical Psychopharmacology. 2011 Aug;31(4):463-469. |
|
| 2011-08 |
Depression trajectories and obesity among the elderly in Taiwan |
Psychological Medicine. 2011 Aug;41(8):1665-1676. |
|
| 2011-08 |
Five-year trajectories of long-term benzodiazepine use by adolescents: Patient, provider, and medication factors |
Psychiatric Services. 2011 Aug;62(8):900-907. |
|
| 2011-06 |
Differential effects of predictors on methylphenidate initiation and discontinuation among young people with newly diagnosed attention-deficit/hyperactivity disorder |
Journal of Child and Adolescent Psychopharmacology. 2011 Jun;21(3):265-273. |
|
| 2011-05 |
Genetic polymorphisms in PXR associated with serum concentration and metabolism to treatment with the antidepressant paroxetine |
Drug Metabolism Reviews. 2011 May;43(Suppl.1):71. |
|
| 2011-05 |
The genetic polymorphisms in ALDH2 influence the methadone dose and adverse reactions in patients with heroin addiction |
Drug Metabolism Reviews. 2011 May;43(Suppl.1):26. |
|
| 2011-05 |
Genetic polymorphisms of CYP2C19 associated with the side effect and serum concentrations of antidepressant paroxetine |
Drug Metabolism Reviews. 2011 May;43(Suppl.1):25-26. |
|
| 2011-05 |
Opioid receptor Mu1 genetic polymorphisms influence QT prolongation and insomnia in methadone maintenance patients |
Biological Psychiatry. 2011 May;69(9 Suppl.1):229S-230S. |
|
| 2011-04 |
ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment |
Pharmacogenetics and Genomics. 2011 Apr;21(4):163-170. |
|
